Pharma & Biotech - Page 3

CG Life, the PE-backed scientific commercialisation agency founded in 2003, has agreed to merge with AI-native agency The Considered+AI in a deal announced this week. Financial terms of the acquisition were not

GSK has unveiled a sweeping three-year cost-savings programme worth £1.9 billion, equivalent to around $2.5 billion, aimed at reshaping how the British drugmaker allocates its resources. The plan, announced by chief executive

Baxter International Inc. has voluntarily recalled a lot of antibiotic intravenous bags after cardboard particles were discovered inside the solution. The recall targets Lot LD175708, expiring 14-Feb 2027, of Cefazolin in Dextrose

Johnson & Johnson (JNJ) has proposed a $5.5 billion settlement to resolve approximately 76,000 ovarian cancer lawsuits filed at both the multi-district litigation and state levels. Law firms representing 99.75% of plaintiffs

Jiangsu Hengrui Pharma and Elevar Therapeutics have seen their hopes for a first-line liver cancer combination approval dashed by two separate FDA citations. The FDA issued complete response letters targeting the combination

Claire Knapp, the chief executive of Havas Lynx UK, is expanding her remit to take on oversight of the agency’s New York operation as part of a significant leadership overhaul. Knapp, who

Sarepta Therapeutics has appointed Michael Severino as its next chief executive officer, effective July 28, the rare disease drugmaker announced on Monday. Severino will succeed Doug Ingram, who announced plans to retire

Gilead Sciences has unveiled a new HIV prevention campaign called “Up to Date,” targeting Black adults who are sexually active, with a particular focus on women. The campaign aims to encourage people

Outlook Therapeutics has secured FDA approval for Lytenava, a reformulated ophthalmic version of Roche’s widely used cancer and eye treatment bevacizumab, after three prior rejections. The New Jersey-based company received the greenlight

The strain on patient access across the United States is intensifying, with rural communities bearing the heaviest burden of a healthcare system under significant financial pressure. More than 200 rural hospitals have